LOS ANGELES CAPITAL MANAGEMENT LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1177206
LOS ANGELES, CA
Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$64,973,277
+$35,976,310 QoQ
Shares Held
130,802
+101.4% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#151
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. VRTX ranks #5 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,973,277 | 130,802 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $28,996,967 | 64,937 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $132,970,941 | 293,301 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $13,892,254 | 35,472 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $14,697,832 | 33,014 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $12,471,024 | 25,723 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $524,315 | 1,302 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $8,709,553 | 18,727 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $30,324,309 | 64,696 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $55,475,779 | 132,714 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $158,635,831 | 389,874 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $148,509,321 | 427,070 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $149,993,895 | 426,228 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $144,035,825 | 457,155 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $129,087,836 | 447,011 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $125,812,658 | 434,526 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $95,094,544 | 337,466 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $92,596,853 | 354,818 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $66,320,298 | 302,005 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $27,957,459 | 154,129 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $34,147,451 | 169,357 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $48,225,613 | 224,420 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $72,571,505 | 307,064 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $86,075,637 | 316,315 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $96,647,682 | 332,912 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $73,883,475 | 310,500 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||